Daniel Sauerstrom is highly experienced in the field of analytical sciences and pharmaceutical development. Daniel has worked in various roles at companies such as United Therapeutics Corporation, Catalent Pharma Solutions, SCYNEXIS, and Milennium Pharmaceuticals. Daniel has a strong background in method development, validation, stability testing, and project management. Daniel holds a Master's degree in Chemistry from Northeastern University and a Bachelor's degree in Chemistry from Tufts University.
June 1, 2023 - present
March, 2022
March, 2019